Endonovo Therapeutics Stock Analysis
| ENDV Stock | USD 0.0009 0.0002 33.33% |
Endonovo Therapeutics is overvalued with Real Value of 3.84E-4 and Hype Value of 4.8E-4. The main objective of Endonovo Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Endonovo Therapeutics is worth, separate from its market price. There are two main types of Endonovo Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Endonovo Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Endonovo |
Endonovo Pink Sheet Analysis Notes
About 25.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Endonovo Therapeutics last dividend was issued on the 20th of December 2019. The entity had 1:1000 split on the 20th of December 2019. Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Endonovo Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Endonovo Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Endonovo Therapeutics call Alan Collier at 800 489 4774 or check out https://www.endonovo.com.Endonovo Therapeutics Investment Alerts
| Endonovo Therapeutics had very high historical volatility over the last 90 days | |
| Endonovo Therapeutics has some characteristics of a very speculative penny stock | |
| Endonovo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 73.11 K. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 58.12 K. | |
| Endonovo Therapeutics currently holds about 59.98 K in cash with (986.58 K) of positive cash flow from operations. | |
| Roughly 25.0% of the company shares are held by company insiders |
Endonovo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Endonovo Therapeutics's market, we take the total number of its shares issued and multiply it by Endonovo Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 21st of January, Endonovo Therapeutics shows the Semi Deviation of 14.09, mean deviation of 11.5, and Downside Deviation of 23.1. Endonovo Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Endonovo Therapeutics standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Endonovo Therapeutics is priced favorably, providing market reflects its regular price of 4.0E-4 per share. As Endonovo Therapeutics appears to be a penny stock we also advise to verify its total risk alpha numbers.Endonovo Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Endonovo Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Endonovo Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Endonovo Therapeutics Outstanding Bonds
Endonovo Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Endonovo Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Endonovo bonds can be classified according to their maturity, which is the date when Endonovo Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| ENERGY TRANSFER PARTNERS Corp BondUS29273RAP47 | View | |
| ENERGY TRANSFER PARTNERS Corp BondUS29273RAR03 | View | |
| ENERGY TRANSFER PARTNERS Corp BondUS29273RAJ86 | View | |
| ENERGY TRANSFER PARTNERS Corp BondUS29273RAZ29 | View | |
| ENERGY TRANSFER PARTNERS Corp BondUS29273RAT68 | View |
Endonovo Therapeutics Predictive Daily Indicators
Endonovo Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Endonovo Therapeutics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Endonovo Therapeutics Forecast Models
Endonovo Therapeutics' time-series forecasting models are one of many Endonovo Therapeutics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Endonovo Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Endonovo Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Endonovo Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Endonovo shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Endonovo Therapeutics. By using and applying Endonovo Pink Sheet analysis, traders can create a robust methodology for identifying Endonovo entry and exit points for their positions.
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Endonovo Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Endonovo Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.